“As we considered the company’s next chapter, it was important to find a partner that understood the qualities that make Medefil special and shared our long-term commitment to its people, customers, and mission. Prairie brings deep industry expertise, complementary capabilities, and the resources to build on the foundation our team has created. We are confident that Prairie is well positioned to guide Medefil through its next phase of growth.”
Medefil
Prairie Capital Fund VII
FDA-approved pharmaceutical manufacturer specializing in prefilled syringe products

